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Background
The β-galactosidase from Kluyveromyces lactis is a protein
with an outstanding biotechnological interest. The main
limitation to its industrial production is the high cost
associated with extraction and downstream processing
due to its intracellular nature [1].
Secretion from yeast is an attractive method for producing
many heterologous proteins both because of the facility
with which genetic manipulations and fermentation can
be carried out and because of the fidelity of posttransla-
tional modifications. However, adding a signal sequence
is not sufficient to lead recombinant proteins out of the
cell: culture conditions play an important role, the wall
acts as a molecular sieve but, moreover, structural deter-
minants, present in the protein, may be required for tar-
geting a protein to the medium [2].
In this work, we have constructed hybrid proteins
between K. lactis β-galactosidase and Aspergillus niger β-
galactosidase, added a signal peptide and analyzed the
secretion and the properties of these new hybrid proteins.
Results
The highest levels of extracellular β-galactosidase were
obtained when the segment corresponding to the five
domain of K. lactis β-galactosidase was replaced by the
corresponding five domain of the A. niger β-galactosidase.
As medium composition can exert a profound effect on
the yield of heterologous protein secretion in yeast, by
influencing both cell growth and the specific rate of secre-
tion [3] we examined hybrid β-galactosidase production
and secretion on batch liquid cultures on several different
media. Best results were obtained in a rich medium in
which pH was maintained at 7.0, since pH values under
6.5 or above 7.5 cause a sharp decrease in K. lactis β-galac-
tosidase activity [4]. In this condition the percentage of
hybrid β-galactosidase secretion was in the exponential
phase 2.2% and reached 16% of the total activity in the
stationary phase.
Conclusion
One strategy for improving the secretion of heterologous
proteins is through introducing structural modifications.
A hybrid protein between K. lactis β-galactosidase and A.
niger β-galactosidase was constructed that increase the
fraction of enzyme reaching the growth medium. Moreo-
ver, we have improved secretion percentages by studying
the influence of the culture conditions on heterologous
hybrid β-galactosidase secretion.
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